Paolo Uva works as a Researcher in the Bioinformatics group of CRS4. He obtained his Laurea (M.S.) degree in biology in 1999 from the Sapienza Universit in Rome, Italy, and then he moved to France where he received, in 2002, a Ph.D. degree in molecular phylogeny from the University of Tours, Blois, France. In 2004 he obtained an M.S. degree in bioinformatics at the University of Geneva (Geneva, Switzerland) and University of Lausanne (Lausanne, Switzerland). As a postdoctoral scientist, Uva worked at the Sapienza University in Rome, Italy, from 2004 to 2005, on the analysis of genome-wide expression data before joining in 2006 the Istituto di Ricerche di Biologia Molecolare (IRBM, owned by Merck & Co. Inc), Rome, where he focused on microarray design, identification of molecular signatures in cancer, and development of molecular biomarkers. In 2009 he moved to CRS4. His research interests include the use of molecular signatures as biomarkers (predictors of prognosis and drug resistance), epigenomics, and study of noncoding RNAs. His research is published in international refereed journals and conferences and he has served as reviewer in the area of functional genomics.
Biography Updated on 6 January 2013